Colchicine (Colchicine Agepha Pharma)
Colchicine AGEPHA Pharma is indicated for secondary prevention of atherothrombotic events in adult patients with coronary disease stable for at least 6 months.
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Colchicine AGEPHA Pharma is indicated for secondary prevention of atherothrombotic events in adult patients with coronary disease stable for at least 6 months.